Journal
SEMINARS IN ARTHRITIS AND RHEUMATISM
Volume 50, Issue 6, Pages 1214-1215Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.semarthrit.2020.09.012
Keywords
COVID-19; SARS-CoV-2; Rheumatic disease; Juvenile idiopathic arthritis; TNF inhibitor